{"input_url":"https://www.ajmc.com/view/fda-panel-backs-6-peptides-for-compounding","gnews_decode":"https://www.ajmc.com/view/fda-panel-backs-6-peptides-for-compounding","http_status":200,"final_url":"https://www.ajmc.com/view/fda-panel-backs-6-peptides-for-compounding","html_length":629839,"trafilatura_result":"ok","text_length":4266,"text_preview":"FDA Panel Backs 6 Peptides for Compounding\nKey Takeaways\n- Six peptides received narrow advisory support for potential 503A Bulks List inclusion, an atypical outcome given FDA staff recommendations against all seven under review.\n- Legal compounding remains prohibited absent FDA acceptance and compl","verdict":"OK"}